Compare ADRX & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADRX | ATLC |
|---|---|---|
| Founded | 2019 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2026 | 2009 |
| Metric | ADRX | ATLC |
|---|---|---|
| Price | $14.58 | $82.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $34.25 | ★ $127.40 |
| AVG Volume (30 Days) | ★ 396.7K | 106.2K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.95 |
| EPS | N/A | ★ 9.62 |
| Revenue | N/A | ★ $1,968,399,000.00 |
| Revenue This Year | $89.41 | $440.35 |
| Revenue Next Year | $510.33 | $12.87 |
| P/E Ratio | ★ N/A | $8.25 |
| Revenue Growth | N/A | ★ 50.09 |
| 52 Week Low | $12.50 | $47.50 |
| 52 Week High | $19.57 | $114.34 |
| Indicator | ADRX | ATLC |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 40.54 |
| Support Level | $12.50 | $74.19 |
| Resistance Level | $18.94 | $94.35 |
| Average True Range (ATR) | 1.59 | 5.78 |
| MACD | -0.16 | -1.40 |
| Stochastic Oscillator | 30.24 | 16.10 |
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.